In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dicerna Pharmaceuticals Inc.

www.dicerna.com

Latest From Dicerna Pharmaceuticals Inc.

Keeping Track: Nektar Withdraws Oxycodegol NDA As Novel Submission Pileup Continues

The latest drug development news and highlights from our US FDA Performance Tracker.

US FDA Performance Tracker Drug Review

Scrip’s Rough Guide On The State Of RNAi

The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.

Business Strategies Companies

Silence Signs Takeda Deal And Sets Sights On US

The resignation of David Horn Solomon last month was a setback for Silence but the company believes it will benefit from the growing prominence given to RNAi technology.

Rare Diseases Business Strategies

Dicerna Ready To Challenge Alnylam’s RNAi Dominance In 2020

Alnylam set for further expansion in ‘gene silencing’ but Dicerna could have best-in-class rival.

Research & Development Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Hepatic (Liver)
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dicerna Pharmaceuticals Inc.
  • Senior Management
  • Douglas, III M Fambrough, PhD, Pres. & CEO
    Jack Green, CFO
    Bob D Brown, PhD, SVP, CSO
    James B Weissman, CBO
    Ralf Rosskamp, MD, CMO
    Rob Ciappenelli, Chief Commercial Officer
  • Contact Info
  • Dicerna Pharmaceuticals Inc.
    Phone: (617) 621-8097
    87 Cambridge Park Dr.
    Cambridge, MA 02140
    USA
UsernamePublicRestriction

Register